Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation

Por Lo Iacono, Marco, Monica, Valentina, Saviozzi, Silvia, Ceppi, Paolo, Bracco, Enrico, Papotti, Mauro, Scagliotti, Giorgio V
Publicado em 2011

S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer

Por Choi, Humberto, Puvenna, Vikram, Brennan, Chanda, Mahmoud, Shamseldeen, Wang, Xiao-Feng, Phillips, Michael, Janigro, Damir, Mazzone, Peter
Publicado no Transl Lung Cancer Res (2016)

Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer

Por Yazawa, Tomohiro, Kaira, Kyoichi, Shimizu, Kimihiro, Shimizu, Akira, Mori, Keita, Nagashima, Toshiteru, Ohtaki, Yoichi, Oyama, Tetsunari, Mogi, Akira, Kuwano, Hiroyuki
Publicado no Am J Transl Res (2016)

Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?

Por Hong, Julian C., Salama, Joseph K.
Publicado no Transl Lung Cancer Res (2016)

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Por El-Zein, Randa A., Etzel, Carol J., Munden, Reginald F.
Publicado no Transl Lung Cancer Res (2018)

Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?

Por Cascales, Almudena, Martinetti, Florent, Belemsagha, Deborah, Le Pechoux, Cecile
Publicado no Transl Lung Cancer Res (2014)

P40. Applying digital tomosynthesis (DTS) to diagnose lung cancer and follow up patients

Por Szondy, Klara, Horvath, Akos, Sutto, Zoltan, Kis, Adrian, Horvath, Gabor, Losonczy, Gyorgy
Publicado no Transl Lung Cancer Res (2014)

P29. Oral topotecan in small cell lung cancer: treatment related side effects

Por Popovic, Filip, Samarzija, Miroslav, Kukulj, Suzana, Redzepi, Gzim, Roglic, Mihovil, Mursic, Davorka, Cucevic, Branka, Plestina, Sanja, Jakopovic, Marko
Publicado no Transl Lung Cancer Res (2014)

Decision analytic modeling for the economic analysis of proton radiotherapy for non-small cell lung cancer

Por Smith, Wade P., Richard, Patrick J., Zeng, Jing, Apisarnthanarax, Smith, Rengan, Ramesh, Phillips, Mark H.
Publicado no Transl Lung Cancer Res (2018)

Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC

Por Prelaj, Arsela, Rebuzzi, Sara Elena, Del Bene, Gabriella, Giròn Berrìos, Julio Rodrigo, Emiliani, Alessandra, De Filippis, Lucilla, Prete, Alessandra Anna, Pecorari, Silvia, Manna, Gaia, Ferrara, Carla, Rossini, Daniele, Longo, Flavia
Publicado no ERJ Open Res (2017)

Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cells

Por Hamilton, Gerhard, Rath, Barbara, Holzer, Sophia, Hochmair, Maximilian
Publicado no Transl Lung Cancer Res (2016)

Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines

Por De Leyn, Paul, Dooms, Christophe, Kuzdzal, Jaroslaw, Lardinois, Didier, Passlick, Bernward, Rami-Porta, Ramon, Turna, Akif, Van Schil, Paul, Venuta, Frederico, Waller, David, Weder, Walter, Zielinski, Marcin
Publicado no Transl Lung Cancer Res (2014)

Treatment of advanced squamous cell carcinoma of the lung: a review

Por Derman, Benjamin A., Mileham, Kathryn F., Bonomi, Philip D., Batus, Marta, Fidler, Mary J.
Publicado no Transl Lung Cancer Res (2015)

Transcriptomic changes induced by mycophenolic acid in gastric cancer cells

Por Dun, Boying, Sharma, Ashok, Xu, Heng, Liu, Haitao, Bai, Shan, Zeng, Lingwen, She, Jin-Xiong
Publicado em 2013

Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis

Por Zhan, Ping, Zhu, Qing-Qing, Miu, Ying-Ying, Liu, Ya-Fang, Wang, Xiao-Xia, Zhou, Ze-Jun, Jin, Jia-Jia, Li, Qian, Sasada, Shinji, Izumo, Takehiro, Tu, Chih-Yen, Cheng, Wen-Chien, Evison, Matthew, Lv, Tang-Feng, Song, Yong
Publicado no Transl Lung Cancer Res (2017)

Smooth sailing for immunotherapy for unresectable stage III non-small cell lung cancer: the PACIFIC study

Por Khandekar, Melin J., Jain, Rakesh
Publicado no Transl Cancer Res (2018)

Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors

Por Sehgal, Kartik, Patell, Rushad, Rangachari, Deepa, Costa, Daniel B.
Publicado no Transl Cancer Res (2018)

From the bench to the bedside—promoting the roles of nurses and allied health professionals in the management of lung cancer and mesothelioma

Por White, John
Publicado no Transl Lung Cancer Res (2016)

Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer

Por Malhotra, Jyoti, Jabbour, Salma K.
Publicado no Transl Lung Cancer Res (2018)

Combination chemotherapy and immunotherapy in metastatic non-small cell lung cancer: a setback for personalized medicine?

Por Chatwal, Monica S., Tanvetyanon, Tawee
Publicado no Transl Lung Cancer Res (2018)